Publisher Correction: Rituximab-associated hypogammaglobulinemia in children with idiopathic nephrotic syndrome: results of an ESPN survey.
作者信息
Zurowska Aleksandra, Drozynska-Duklas Magdalena, Topaloglu Rezan, Bouts Antonia, Boyer Olivia, Shenoy Mohan, Vivarelli Marina
机构信息
Department of Pediatrics, Nephrology and Hypertension, Medical University of Gdańsk, ul. Debinki 7, 80-952, Gdańsk, Poland.
Centre for Rare Diseases, Medical University of Gdańsk, Gdańsk, Poland.
出版信息
Pediatr Nephrol. 2025 Mar;40(3):877-878. doi: 10.1007/s00467-024-06625-w.
Abstract
摘要
相似文献
1
Publisher Correction: Rituximab-associated hypogammaglobulinemia in children with idiopathic nephrotic syndrome: results of an ESPN survey.出版商更正：利妥昔单抗相关低丙种球蛋白血症在特发性肾病综合征儿童中的情况：ESPN 调查结果
Pediatr Nephrol. 2025 Mar;40(3):877-878. doi: 10.1007/s00467-024-06625-w.
2
Rituximab-associated hypogammaglobulinemia in children with idiopathic nephrotic syndrome: results of an ESPN survey.特利珠单抗相关低丙种球蛋白血症在特发性肾病综合征儿童中的表现：一项 ESPN 调查的结果。
Pediatr Nephrol. 2023 Sep;38(9):3035-3042. doi: 10.1007/s00467-023-05913-1. Epub 2023 Apr 4.
3
Incidence and risk factors of rituximab-associated hypogammaglobulinemia in patients with complicated nephrotic syndrome.复杂型肾病综合征患者中利妥昔单抗相关低丙种球蛋白血症的发病率及危险因素
Pediatr Nephrol. 2022 May;37(5):1057-1066. doi: 10.1007/s00467-021-05304-4. Epub 2021 Oct 4.
4
The association between hypogammaglobulinemia severity and infection risk in rituximab-treated patients with childhood-onset idiopathic nephrotic syndrome.利妥昔单抗治疗的儿童期起病的特发性肾病综合征患者低丙种球蛋白血症严重程度与感染风险之间的关联。
Pediatr Nephrol. 2023 Feb;38(2):451-460. doi: 10.1007/s00467-022-05652-9. Epub 2022 Jun 24.
5
Immunoglobulin serum levels in rituximab-treated patients with steroid-dependent nephrotic syndrome.利妥昔单抗治疗的激素依赖性肾病综合征患者的血清免疫球蛋白水平。
Pediatr Nephrol. 2020 Mar;35(3):455-462. doi: 10.1007/s00467-019-04398-1. Epub 2019 Nov 8.
6
Long-Term Efficacy and Safety of Repeated Rituximab to Maintain Remission in Idiopathic Childhood Nephrotic Syndrome: An International Study.重复利妥昔单抗维持缓解治疗特发性儿童肾病综合征的长期疗效和安全性：一项国际研究。
J Am Soc Nephrol. 2022 Jun;33(6):1193-1207. doi: 10.1681/ASN.2021111472. Epub 2022 Mar 30.
7
Use of Rituximab in Childhood Idiopathic Nephrotic Syndrome.利妥昔单抗在儿童特发性肾病综合征中的应用。
Clin J Am Soc Nephrol. 2023 Apr 1;18(4):533-548. doi: 10.2215/CJN.08570722. Epub 2023 Feb 22.
8
Anti-CD20 Antibodies for Idiopathic Nephrotic Syndrome in Children.抗CD20抗体用于儿童特发性肾病综合征
Clin J Am Soc Nephrol. 2016 Apr 7;11(4):710-20. doi: 10.2215/CJN.08500815. Epub 2015 Nov 19.
9
Publisher Correction: Management of congenital nephrotic syndrome: consensus recommendations of the ERKNet-ESPN Working Group.出版商更正：先天性肾病综合征的管理：ERKNet-ESPN工作组的共识建议。
Nat Rev Nephrol. 2021 Jun;17(6):434. doi: 10.1038/s41581-021-00431-5.
10
Variability of diagnostic criteria and treatment of idiopathic nephrotic syndrome across European countries.欧洲各国特发性肾病综合征诊断标准与治疗的差异
Eur J Pediatr. 2017 May;176(5):647-654. doi: 10.1007/s00431-017-2891-2. Epub 2017 Mar 16.
引用本文的文献
1
Bridging pediatric and adult IgAN: challenges in applying proteinuria-driven recommendations in the new IPNA guidelines.连接儿童和成人IgA肾病：在新的国际儿科肾脏病学会（IPNA）指南中应用蛋白尿驱动建议面临的挑战
Pediatr Nephrol. 2025 Jan 9. doi: 10.1007/s00467-024-06648-3.
Zotero 插件